108 related articles for article (PubMed ID: 5360987)
1. Transport and binding of chloroguanide-triazine by rat liver slices.
Gigon PL; Nayak PK; Schanker LS
Proc Soc Exp Biol Med; 1969 Dec; 132(3):1103-9. PubMed ID: 5360987
[No Abstract] [Full Text] [Related]
2. Active transport of tertiary amine compounds into bile.
Nayak PK; Schanker LS
Am J Physiol; 1969 Dec; 217(6):1639-43. PubMed ID: 5353038
[No Abstract] [Full Text] [Related]
3. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
[TBL] [Abstract][Full Text] [Related]
4. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
Ward SA; Watkins WM; Mberu E; Saunders JE; Koech DK; Gilles HM; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1989 Jun; 27(6):781-7. PubMed ID: 2757894
[TBL] [Abstract][Full Text] [Related]
5. [CROSSED RESISTANCE OF P. GALLINACEUM WITH RESPECT TO PROGUANIL AND ITS ACTIVE TRIAZINE METABOLITE].
BENAZET F
Bull Soc Pathol Exot Filiales; 1964; 57():371-5. PubMed ID: 14250509
[No Abstract] [Full Text] [Related]
6. Correlation between proguanil and metabolites in plasma and saliva.
Alexander C; Nathwani D; Zimbler N; Taylor RB
J Antimicrob Chemother; 1995 Dec; 36(6):1113-5. PubMed ID: 8821621
[No Abstract] [Full Text] [Related]
7. In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.
Birkett DJ; Rees D; Andersson T; Gonzalez FJ; Miners JO; Veronese ME
Br J Clin Pharmacol; 1994 May; 37(5):413-20. PubMed ID: 8054246
[TBL] [Abstract][Full Text] [Related]
8. OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.
Matthaei J; Seitz T; Jensen O; Tann A; Prukop T; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
Clin Pharmacol Ther; 2019 Jan; 105(1):190-200. PubMed ID: 29882324
[TBL] [Abstract][Full Text] [Related]
9. Human pharmacokinetics of proguanil and its metabolites.
Bygbjerg I; Ravn P; Rønn A; Flachs H; Hvidberg EF
Trop Med Parasitol; 1987 Jun; 38(2):77-80. PubMed ID: 3629140
[TBL] [Abstract][Full Text] [Related]
10. Improved validated assay for the determination of proguanil and its metabolites in plasma, whole blood, and urine using solid-phase extraction and high-performance liquid chromatography.
Bergqvist Y; Funding L; Krysèn B; Leek T; Yvell K
Ther Drug Monit; 1998 Jun; 20(3):325-30. PubMed ID: 9631931
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of proguanil in human subjects following a single oral dose.
Chiluba EM; Fletcher KA; Price AH
Afr J Med Med Sci; 1987 Mar; 16(1):43-6. PubMed ID: 3037875
[TBL] [Abstract][Full Text] [Related]
12. Experiments with antimalarial drugs in man. V. Experiments with an active metabolite of proguanil and an active metabolite of 5943.
ROBERTSON GI
Trans R Soc Trop Med Hyg; 1957 Nov; 51(6):488-92. PubMed ID: 13496181
[No Abstract] [Full Text] [Related]
13. Myo-inositol transport in slices of rat kidney cortex. I. Effect of incubation conditions and inhibitors.
Hauser G
Biochim Biophys Acta; 1969 Mar; 173(2):257-66. PubMed ID: 5774776
[No Abstract] [Full Text] [Related]
14. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
[TBL] [Abstract][Full Text] [Related]
16. Proguanil, the isolation of a metabolite with high antimalarial activity.
CROWTHER AF; LEVI AA
Br J Pharmacol Chemother; 1953 Mar; 8(1):93-7. PubMed ID: 13066702
[No Abstract] [Full Text] [Related]
17. The mode of action of proguanil and related antimalarial drugs.
RYLEY JF
Br J Pharmacol Chemother; 1953 Dec; 8(4):424-30. PubMed ID: 13115632
[No Abstract] [Full Text] [Related]
18. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
[TBL] [Abstract][Full Text] [Related]
19. Action of proguanil and its metabolite on neuromuscular and synaptic transmission.
DALLEMAGNE MJ; PHILIPPOT E
Br J Pharmacol Chemother; 1955 Jun; 10(2):147-52. PubMed ID: 14389651
[No Abstract] [Full Text] [Related]
20. Cardiopulmonary effects of antimalarial drugs. V. Cycloguanil and a new triazine compound (WR 99,662).
Ruiz R; Grigas EO; Aviado DM
Toxicol Appl Pharmacol; 1971 Feb; 18(2):487-97. PubMed ID: 4398207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
